Malaysia’s medicine stock stable for now, but govt’s main supplier sets up task force over disruption risk

 

The Health Ministry says that there is an adequate supply of medicine as of March 27, 2026 to meet domestic demand for the next few months despite the West Asia conflict. — File picture by Hari Anggara

KUALA LUMPUR, March 27 — Malaysia’s medicine supply remains stable for the next few months, even as global trade disruptions caused by the conflict in West Asia threaten pharmaceutical supply chains worldwide.

Pharmaniaga Berhad, the country’s main supplier of medicines to public healthcare facilities, has formed an internal task force to evaluate alternative sourcing strategies and safeguard continuity of essential drug supplies.

“Our inventory position is stable, supported by adequate buffer stocks to meet current demand nationwide,” Pharmaniaga managing director Datuk Zulkifli Jafar told Malay Mail in a statement today.

He said that while minor adjustments have been made to the delivery timelines from certain supplier countries, Malaysia’s medicine distribution has not been affected.

He said the task force will coordinate risk assessment and response planning across the company’s supply chain, logistics, manufacturing, procurement, and finance functions.

He added that the situation underscores the need to strengthen Malaysia’s domestic pharmaceutical manufacturing capabilities to ensure long-term medicine security.

“Developments in global oil prices are also being observed carefully, as these may affect freight and certain raw material costs within the broader supply chain,” he said. - malaymail